Wuesthoff & Wuesthoff Und Rechtsanwalt competitive analysis

Explore patent oppositions filed by Wuesthoff & Wuesthoff Und Rechtsanwalt against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use ThereofEISAI R&D MANAGEMENTApr 1, 2026
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025
Solid Oral Formulation Of FenretinideLAURENT PHARMACEUTICALSSep 9, 2025
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XCHUGAI SEIYAKU KABUSHIKI KAISHAAug 25, 2025
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 6, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 10, 2025
Xylylene Diisocyanate Composition, Modified Xylylene Diisocyanate Composition, Polymerizable Composition, Resin, Molded Body, Optical Element, And LensMITSUI CHEMICALSFeb 12, 2025
Guide Rna With Chemical ModificationsAGILENTJan 14, 2025
Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024

Latest PTAB cases involving Wuesthoff & Wuesthoff Und Rechtsanwalt

Discover the latest PTAB cases involving Wuesthoff & Wuesthoff Und Rechtsanwalt, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Wuesthoff & Wuesthoff Und Rechtsanwalt with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WUESTHOFF & WUESTHOFF UND RECHTSANWALT15 - - -
ACCELERON PHARMA - 7 - -
BOEHRINGER INGELHEIM3321489
NOVARTIS6520 - 21